These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22315080)

  • 1. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments.
    Su YZ; Li HJ; Li YQ; Chen HJ; Tang DS; Zhang X; Jiang H; Zhou TH
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):210-4. PubMed ID: 15756425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
    Smith A; Zhang I; Trang P; Liu F
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of an engineered M1GS-HCV/C141 ribozyme and determination of its antiviral activity in vitro].
    Li X; Zhang W; Huang Z; Zhang C; Luo G
    Sheng Wu Gong Cheng Xue Bao; 2013 Dec; 29(12):1786-95. PubMed ID: 24660626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
    Trang P; Smith A; Liu F
    Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.